Aytu Biopharma (AYTU) Amortization - Intangibles (2015 - 2026)
Aytu Biopharma (AYTU) posted quarterly Amortization - Intangibles of $761000.0 for Q1 2026, down 17.28% year-over-year from $920000.0 in Q1 2025, and up 44.68% quarter-over-quarter from $526000.0 in Q4 2025.
Aytu Biopharma (AYTU) Amortization - Intangibles (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Amortization - Intangibles for 12 consecutive years, with $761000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization - Intangibles fell 17.28% year-over-year to $761000.0; the TTM figure through Mar 2026 stood at $2.7 million (down 27.99% YoY), while the FY2025 annual figure was $3.7 million, changed 0.0% from the prior year.
- Amortization - Intangibles advanced to $761000.0 in Q1 2026 per AYTU's latest filing, from $526000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $1.5 million in Q1 2022 and bottomed at $444000.0 in Q3 2025.
- Historically, Amortization - Intangibles has averaged $981588.2 across 5 years, with a median of $921000.0 in 2024.
- Annual changes were most pronounced in 2022 — Amortization - Intangibles gained 3.43% — and 2025, when it plunged 51.79%.
- Aytu Biopharma's Amortization - Intangibles stood at $1.2 million in 2022, then slipped by 23.37% to $918000.0 in 2023, then grew by 0.33% to $921000.0 in 2024, then sank by 42.89% to $526000.0 in 2025, then soared by 44.68% to $761000.0 in 2026.
- Business Quant data shows AYTU's Amortization - Intangibles at $761000.0 in Q1 2026, $526000.0 in Q4 2025, and $444000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 761,000.00 |
| Dec 31, 2025 | 526,000.00 |
| Sep 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 921,000.00 |
| Mar 31, 2025 | 920,000.00 |
| Dec 31, 2024 | 921,000.00 |
| Sep 30, 2024 | 921,000.00 |
| Jun 30, 2024 | 921,000.00 |
| Mar 31, 2024 | 920,000.00 |
| Dec 31, 2023 | 918,000.00 |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 1.26 Mn |